349 related articles for article (PubMed ID: 31411084)
1. Advances in preclinical approaches to Chagas disease drug discovery.
Villalta F; Rachakonda G
Expert Opin Drug Discov; 2019 Nov; 14(11):1161-1174. PubMed ID: 31411084
[No Abstract] [Full Text] [Related]
2. Phenotypic screening approaches for Chagas disease drug discovery.
Chatelain E; Ioset JR
Expert Opin Drug Discov; 2018 Feb; 13(2):141-153. PubMed ID: 29235363
[TBL] [Abstract][Full Text] [Related]
3. Current advances in drug discovery for Chagas disease.
Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
[TBL] [Abstract][Full Text] [Related]
4. Novel drug discovery for Chagas disease.
Moraes CB; Franco CH
Expert Opin Drug Discov; 2016; 11(5):447-55. PubMed ID: 26967915
[TBL] [Abstract][Full Text] [Related]
5. Therapeutical approaches under investigation for treatment of Chagas disease.
Bahia MT; Diniz Lde F; Mosqueira VC
Expert Opin Investig Drugs; 2014 Sep; 23(9):1225-37. PubMed ID: 24855989
[TBL] [Abstract][Full Text] [Related]
6. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
[TBL] [Abstract][Full Text] [Related]
7. Lead identification to clinical candidate selection: drugs for Chagas disease.
Neitz RJ; Chen S; Supek F; Yeh V; Kellar D; Gut J; Bryant C; Gallardo-Godoy A; Molteni V; Roach SL; Khare S; Stinson M; Chatterjee AK; Robertson S; Renslo AR; Arkin M; Glynne R; McKerrow J; Siqueira-Neto JL
J Biomol Screen; 2015 Jan; 20(1):101-11. PubMed ID: 25281737
[TBL] [Abstract][Full Text] [Related]
8. Drug discovery for chagas disease: A viewpoint.
Kratz JM
Acta Trop; 2019 Oct; 198():105107. PubMed ID: 31351074
[TBL] [Abstract][Full Text] [Related]
9. Why hasn't there been more progress in new Chagas disease drug discovery?
Vermelho AB; Rodrigues GC; Supuran CT
Expert Opin Drug Discov; 2020 Feb; 15(2):145-158. PubMed ID: 31670987
[No Abstract] [Full Text] [Related]
10. Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015).
Rodriguez JB; Falcone BN; Szajnman SH
Expert Opin Ther Pat; 2016 Sep; 26(9):993-1015. PubMed ID: 27376456
[TBL] [Abstract][Full Text] [Related]
11. Emerging agents for the treatment of Chagas disease: what is in the preclinical and clinical development pipeline?
Martínez-Peinado N; Cortes-Serra N; Losada-Galvan I; Alonso-Vega C; Urbina JA; Rodríguez A; VandeBerg JL; Pinazo MJ; Gascon J; Alonso-Padilla J
Expert Opin Investig Drugs; 2020 Sep; 29(9):947-959. PubMed ID: 32635780
[TBL] [Abstract][Full Text] [Related]
12. Challenges in Chagas Disease Drug Discovery: A Review.
Paucar R; Moreno-Viguri E; Pérez-Silanes S
Curr Med Chem; 2016; 23(28):3154-3170. PubMed ID: 27356544
[TBL] [Abstract][Full Text] [Related]
13. Biological factors that impinge on Chagas disease drug development.
Francisco AF; Jayawardhana S; Lewis MD; Taylor MC; Kelly JM
Parasitology; 2017 Dec; 144(14):1871-1880. PubMed ID: 28831944
[TBL] [Abstract][Full Text] [Related]
14. High throughput screening for anti-Trypanosoma cruzi drug discovery.
Alonso-Padilla J; Rodríguez A
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3259. PubMed ID: 25474364
[TBL] [Abstract][Full Text] [Related]
15. Chagas disease drug discovery: toward a new era.
Chatelain E
J Biomol Screen; 2015 Jan; 20(1):22-35. PubMed ID: 25245987
[TBL] [Abstract][Full Text] [Related]
16. Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box.
Cantizani J; Gamallo P; Cotillo I; Alvarez-Velilla R; Martin J
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009602. PubMed ID: 34270544
[TBL] [Abstract][Full Text] [Related]
17. Potential new clinical therapies for Chagas disease.
Bustamante JM; Tarleton RL
Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
[TBL] [Abstract][Full Text] [Related]
18. Target-based Screening of the Chagas Box: Setting Up Enzymatic Assays to Discover Specific Inhibitors Across Bioactive Compounds.
Salas-Sarduy E; Niemirowicz GT; José Cazzulo J; Alvarez VE
Curr Med Chem; 2019; 26(36):6672-6686. PubMed ID: 31284853
[TBL] [Abstract][Full Text] [Related]
19. Animal models of Chagas disease and their translational value to drug development.
Chatelain E; Scandale I
Expert Opin Drug Discov; 2020 Dec; 15(12):1381-1402. PubMed ID: 32812830
[TBL] [Abstract][Full Text] [Related]
20. Clear Shot at Primary Aim: Susceptibility of Trypanosoma cruzi Organelles, Structures and Molecular Targets to Drug Treatment.
Menna-Barreto RF; de Castro SL
Curr Top Med Chem; 2017; 17(10):1212-1234. PubMed ID: 27784255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]